University Hospitals Seidman Cancer Center researchers have developed a tool that could identify metastatic prostate cancer ...
Researchers at the UCLA Health Jonsson Comprehensive Cancer Center have launched a clinical trial, called ANDROMEDA, to ...
News-Medical.Net on MSN
PSA-based tool improves decision making for prostate cancer screening and treatment
In a previous study, the researchers showed that PSA scores can impact both doctor and patient behavior, leading to biopsy ...
The Prostate Cancer Foundation has partnered with the Naismith Basketball Hall of Fame to host the launch of their “Check the ...
11don MSN
Easy-to-use tool can identify high- and low-risk metastatic prostate cancer patients earlier
A new study published in Nature Communications provides a framework for researching whether earlier, model-guided treatment ...
To help meet the potentially complex needs of patients after prostate cancer treatment and offer the precision and care ...
Investigators designed and externally validated a prostate cancer death prediction model for risk stratification of men at the point of PSA screening.
Model was developed from the prostate cancer screening group of the PLCO and validated externally in a VA population ...
The Chinese regulator has accepted the New Drug Application for Illuccix, Telix’s lead imaging agent for prostate cancer. The ...
Investigators sought to evaluate changes in the estimated CV risk of men with prostate cancer after 6 months of hormone therapy using clinical tools established for the general population. A post-hoc ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results